The following list represents Studies for which calls for participation are currently open. Learn about the individual studies below, and click the link to find out more about the Working Party responsible for the study.
Dear Colleague,
On behalf of the EBMT Nurses Group, we kindly invite you to participate in a survey on the implementation of oral care guidelines in hematopoietic cell transplantation (HCT) and cellular therapy (CT).
The aim of this study is to assess the adoption and routine use of oral care guidelines and to identify factors influencing their implementation in clinical practice. The survey focuses specifically on oral care during the transplant process, including conditioning and aplasia/neutropenia phases in both adult and pediatric settings.
We are particularly interested in input from clinicians involved in transplant care, including physicians and nursing professionals, to capture current practices across EBMT centers.
Please complete one questionnaire per program (adult or pediatric) and if needed, you may consult colleagues or forward the survey to the person most knowledgeable about oral care practices in your center.
The survey takes approximately 15-20 minutes to complete. The deadline for completing the survey is on Sunday 14 June 2026.
Access the survey here: https://www.surveymonkey.com/r/SH9FK8Q
Thank you in advance for your participation.
Best regards,
Carlotta Cadsky – Principal Investigator
Lynn Leppla – Chair Nurses Group Research Committee
Annika Kisch – Nurses Group Research Committee Representative
Hilda Mekelenkamp – President Nurses Group
Jarl Mooyaart – Statistician
Brian Piepenbroek – Study Coordinator
This project consists of two parts:
- A centre-level survey (can be completed even if you do not wish to participate in the patient-level study). The survey will take approximately 20 minutes to complete and the link can be found below (click the button 'Take the survey')
- Collecting patient data in a retrospective patient-level study
Inclusion criteria for the patient-level study:
- Having received allogeneic or autologous HCT between 01/01/2020 and 31/08/2025 which is fully registered in the EBMT registry
- Adults and children
- With documented Carbapenem Resistant-Gram Negative (CR-GN) colonisation within 3 months prior to HCT, or
- CR-GN infection within 3 months prior to HCT and resolved at the time of onset of conditioning
Data for the patient-level study is collected via our EBMT registry. The study specific questionnaire can be added to the patient's timeline after you have logged in to the registry. If you do not have access, please check with your datamanager or request access to the the registry.
In case of questions, please contact the IDWP study office